Quantitative collagen and liver fibrosis by morphometric assessment in chronic hepatitis B patients treated with long term tenofovir disoproxil fumarate (TDF)

被引：0
|
作者：
Chan, Alain
Goodman, Zachary
Afdhal, Nezam
Buti, Maria
Gane, Edward
Krastev, Zachary
Alaparthi, Lakshmi
Monge, Fanny
Schall, Raul Aguilar
Kim, Sun Sook
Bornstein, Jeffrey
Mchutchison, John
Dusheiko, Geoffrey
Kaita, Kelly
Manns, Michael
Marcellin, Patrick
机构：
[1] Inova Hlth Syst, Falls Church, VA USA
[2] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
[3] Hosp Univ Valle Hebron, Madrid, Spain
[4] Auckland City Hosp, Auckland, New Zealand
[5] Gilead Sci, Foster City, CA USA
[6] Royal Free & Univ Coll, London, England
[7] Univ Manitoba, Winnipeg, MB R3T 2N2, Canada
[8] Hannover Med Sch, Hannover, Germany
[9] Hop Beaujon, Clichy, France
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2014年 / 29卷
关键词：
collagen; liver fibrosis; morphometric assessment; chronic hepatitis B; tenofovir; tenofovir disoproxil fumarate;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-374
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [1] Morphometric Assessment of Quantitative Collagen and Liver Fibrosis in Patients with Chronic Hepatitis B (CHB) Treated for up to Five Years with Tenofovir Disoproxil Fumarate (TDF)
    Goodman, Zachary D.
    Afdhal, Nezam H.
    Buti, Maria
    Gane, Edward J.
    Krastev, Zahary
    Schall, Raul E. Aguilar
    Kim, Sun Sook
    Alaparthi, Lakshmi
    Monge, Fanny
    Emmett, Caroline
    Bornstein, Jeffrey
    Subramanian, Mani
    McHutchison, John G.
    Dusheiko, Geoffrey M.
    Kaita, Kelly D.
    Manns, Michael P.
    Marcellin, Patrick
    HEPATOLOGY, 2013, 58 : 596A - 597A
  • [2] Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
    Liaw, Yun-Fan
    Sheen, I-Shyan
    Lee, Chuan-Mo
    Akarca, Ulus Salih
    Papatheodoridis, George V.
    Wong, Florence Suet-Hing
    Chang, Ting-Tsung
    Horban, Andrzej
    Wang, Chia
    Kwan, Peter
    Buti, Maria
    Prieto, Martin
    Berg, Thomas
    Kitrinos, Kathryn
    Peschell, Ken
    Mondou, Elsa
    Frederick, David
    Rousseau, Franck
    Schiff, Eugene R.
    HEPATOLOGY, 2011, 53 (01) : 62 - 72
  • [3] PREDICTORS OF LIVER STIFFNESS CHANGES IN CHRONIC HEPATITIS B (CHB) PATIENTS UNDER LONG-TERM THERAPY WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)
    Kranidioti, Hariklia
    Protopapas, Adonis A.
    Voulgaris, Theodoros
    Tsolias, Chrisostomos
    Antonakaki, Pinelopi
    Deutsch, Melanie
    Triantos, Christos
    Goulis, John
    Papatheodoridis, George
    Manolakopoulos, Spilios
    GASTROENTEROLOGY, 2021, 160 (06) : S822 - S822
  • [4] MACHINE LEARNING ENABLES QUANTITATIVE ASSESSMENT OF HISTOPATHOLOGIC SIGNATURES ASSOCIATED WITH ALT NORMALIZATION IN CHRONIC HEPATITIS B PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)
    Shukla, Chinmay
    Carrasco-Zevallos, Oscar
    Juyal, Dinkar
    Le, Ngoc Han Quang
    Mountain, Victoria
    Pokkalla, Harsha
    Resnick, Murray
    Montalto, Michael
    Beck, Andrew
    Wapinski, Ilan
    Marcellin, Patrick
    Ferret, Maria Asuncion Buti
    Janssen, Harry L. A.
    Flaherty, John F.
    Suri, Vithika
    Gaggar, Anuj
    Jacobson, Ira M.
    Gane, Edward J.
    HEPATOLOGY, 2020, 72 : 15A - 15A
  • [5] HEPATIC STEATOSIS DOES NOT PREDICT REGRESSION OF LIVER CIRRHOSIS IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)
    Buti, M.
    Washington, M. K.
    Gane, E.
    Schall, R. Aguilar
    Bornstein, J. D.
    Subramanian, M.
    McHutchison, J. G.
    Flisiak, R.
    Janssen, H. L. A.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S294 - S295
  • [6] From Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Perspectives in Pediatric Patients with Chronic Hepatitis B
    Rodrigo, Minna
    Hartley, Christopher
    Wasuwanich, Paul
    Van, Trung
    Karnsakul, Wikrom
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (12) : 1099 - 1106
  • [7] Factors associated with regression of cirrhosis in patients with chronic hepatitis B (CHB) infection treated with tenofovir disoproxil fumarate (TDF)
    Gane, Ed
    Afdhal, Nezam
    Buti, Maria
    Elsome, Amanda M.
    Flaherty, John F.
    Martins, Eduardo
    Bekele, Neby
    Bornstein, Jeffrey D.
    Marcellin, Patrick
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 164 - 164
  • [8] CHARACTERIZATION OF HBSAG KINETICS AND HBSAG SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)
    Marcellin, Patrick
    Heathcote, E. Jenny
    Buti, Maria
    Krastev, Zahary
    Jacobson, Ira M.
    de Man, Robert A.
    Dusheiko, Geoffrey M.
    Zeuzem, Stefan
    Barnes, Chris N.
    Lou, Lillian
    HEPATOLOGY, 2011, 54 : 1036A - 1036A
  • [9] HBSAG KINETICS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR UP TO 4 YEARS
    Marcellin, P.
    Heathcote, E. J.
    Buti, M.
    Krastev, Z.
    Jacobson, I.
    de Man, R. A.
    Dusheiko, G.
    Zeuzem, S.
    Barnes, C.
    Ng, C.
    Lou, L.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S297 - S297
  • [10] REST-B STUDY: LIVER FIBROSIS REGRESSION ASSESSED BY TRANSIENT ELASTOGRAPHY (TE) IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) ON LONG TERM MAINTENANCE THERAPY WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)
    Kranidioti, Hariklia
    Koustenis, Kanellos-Rafail
    Protopapas, Adonis A.
    Voulgaris, Theodoros
    Tsolias, Chrisostomos
    Deutsch, Melanie
    Triantos, Christos
    Goulis, John
    Papatheodoridis, George
    Manolakopoulos, Spilios
    GASTROENTEROLOGY, 2019, 156 (06) : S1336 - S1337
12345